{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "adds_modification",
    "modifications" : [ {
      "position" : "Ser-239",
      "modification_type" : "phosphorylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P50552",
      "entity_text" : "VASP",
      "entity_type" : "protein"
    },
    "is_direct" : false,
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03136",
      "entity_text" : "CORM-A1",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Western blot analysis of lung tissue harvested from mice with induced endothelial dysfunction (pretreated with LPS) and treated with lower (L) and higher (H) doses of CORM-A1 and DETA/NO revealed that in combination therapy group treated with higher doses, significant decrease of vasodilator stimulated phosphoprotein (VASP) and VASP phosphorylated at Ser 239 (pVASP Ser239) level was noticed.",
  "reading_complete" : "2020-08-02T10:53:54Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T10:51:55Z",
  "trigger" : "stimulated",
  "evidence" : [ "CORM-A1 and DETA/NO revealed that in combination therapy group treated with higher doses, significant decrease of vasodilator-stimulated phosphoprotein (VASP)                      and VASP phosphorylated at Ser-239" ],
  "pmc_id" : "6587338",
  "score" : 0
}